Syros Pharmaceuticals, Inc.
SYRSDelisted Mar 10, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001556263
Syros Pharmaceuticals, Inc. was delisted on Mar 10, 2025; its insiders filed their last Form 4 on Dec 4, 2024; 44 institutions reported holding it in 13F filings for Q4 2024, worth $1.20M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Syros Pharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 53 | 2 | 48 | −3 |
| Shares | 10.6M | 1.14K | 12.1M | +1.51M (+14.3%) |
| Value | $33.5M | $3.58K | $47.9M | +$14.5M (+43.2%) |
2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held Syros Pharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Deep Track Capital, LP | 828,485 | $3.27M | 0.13% |
| Clarius Group, LLC | 18,620 | $73.5K | 0.01% |
| UBS Group AG | 1,093 | $4.32K | 0.00% |
Sold out (6)
Institutions that held Syros Pharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Gsa Capital Partners LLP | 27,460 | $86.0K |
| Two Sigma Investments, LP | 19,584 | $61.7K |
| Millennium Management LLC | 12,825 | $40.4K |
| Dimensional Fund Advisors LP | 12,015 | $37.8K |
| CarsonAllaria Wealth Management, Ltd. | 104 | $328 |
| Signaturefd, LLC | 87 | $274 |
Not filed for Q3 2023 yet (2)
Institutions that held Syros Pharmaceuticals, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| First Capital Advisors Group, LLC. | 1,123 | $3.54K |
| Cowen Prime Advisors LLC | 13 | $41 |